GSK sales top forecasts |
27-Apr-2022 |
ShareCast |
US FDA accepts GSK application for kidney diseas... |
19-Apr-2022 |
ShareCast |
GSK agrees to buy Sierra Oncology for $1.9bn |
13-Apr-2022 |
ShareCast |
GSK's Cabenuva receives approved label update fr... |
24-Mar-2022 |
ShareCast |
EU accepts GSK marketing application for kidney ... |
01-Mar-2022 |
ShareCast |
GSK to spin off consumer healthcare unit in July |
28-Feb-2022 |
ShareCast |
Glaxo halts trial of respiratory virus maternal ... |
28-Feb-2022 |
ShareCast |
GSK and Sanofi seek approval for Covid-19 jab |
23-Feb-2022 |
ShareCast |
Glaxo pauses enrolment and vaccination in RSV va... |
18-Feb-2022 |
ShareCast |
Director dealings: GSK execs sell shares for tax... |
17-Feb-2022 |
ShareCast |
Glaxo's Benlysta lupus treatment approved in Chi... |
10-Feb-2022 |
ShareCast |
GSK Covid sales soar but sees slowdown next year |
09-Feb-2022 |
ShareCast |
Wednesday preview: Fedspeak, GSK in the spotlight |
08-Feb-2022 |
ShareCast |
Glaxo's ViiV Healthcare settles patent row with ... |
02-Feb-2022 |
ShareCast |
Glaxo's ViiV Healthcare gets FDA approval for HI... |
01-Feb-2022 |
ShareCast |
Unilever said to be planning layoffs after activ... |
25-Jan-2022 |
ShareCast |
Unilever won't lift £50bn offer for GSK consumer... |
19-Jan-2022 |
ShareCast |
GSK chief science officer leaves to join US star... |
19-Jan-2022 |
ShareCast |
Unilever says GSK consumer arm 'strategic fit', ... |
17-Jan-2022 |
ShareCast |
BoA stays 'neutral' on Unilever, says upside and... |
17-Jan-2022 |
ShareCast |
GlaxoSmithKline's ViiV Healthcare receives FDA a... |
21-Dec-2021 |
ShareCast |
Glaxo appoints ex-Tesco boss as chair of new con... |
20-Dec-2021 |
ShareCast |
GlaxoSmithKline Covid treatment approved for use... |
17-Dec-2021 |
ShareCast |
GSK-Sanofi Covid jab shows 'strong' immune respo... |
15-Dec-2021 |
ShareCast |
Medicago and GSK's Covid-19 vaccine shows 75.3% ... |
07-Dec-2021 |
ShareCast |
GSK-Vir drug works against all Omicron variants ... |
07-Dec-2021 |
ShareCast |
GSK says its Covid-19 treatment works on Omicron |
02-Dec-2021 |
ShareCast |
Glaxo poaches new head of vaccines Phil Dormitze... |
30-Nov-2021 |
ShareCast |
US secures $1bn of GSK-Vir Covid-19 treatment - ... |
17-Nov-2021 |
ShareCast |
EU approves Glaxo's Nucala treatment |
17-Nov-2021 |
ShareCast |
GlaxoSmithKline denies interest in Aurinia |
01-Nov-2021 |
ShareCast |
Sunday newspaper round-up: Heathrow, GSK, Roll-R... |
31-Oct-2021 |
ShareCast |
Glaxo upgrades FY EPS guidance after strong Q3 |
27-Oct-2021 |
ShareCast |
Wednesday preview: Autumn Budget, GSK in focus |
26-Oct-2021 |
ShareCast |
Berenberg says GSK 'undervalued' but pipeline un... |
18-Oct-2021 |
ShareCast |
Glaxo's consumer arm drawing interest from priva... |
12-Oct-2021 |
ShareCast |
Glaxo unveils plans for £120m consumer healhcare... |
11-Oct-2021 |
ShareCast |
GSK, SK Bioscience to start Phase 3 Covid vaccin... |
31-Aug-2021 |
ShareCast |
Wednesday broker round-up |
18-Aug-2021 |
ShareCast |
Tuesday broker round-up |
17-Aug-2021 |
ShareCast |
Sunday newspaper round-up: Meggitt, GlaxoSmithKl... |
15-Aug-2021 |
ShareCast |
GlaxoSmithKline Q2 profits, revenue jump |
28-Jul-2021 |
ShareCast |
GSK and Vir Biotechnology to supply EU with Cov... |
28-Jul-2021 |
ShareCast |
GSK appoints McNamara as CEO designate of consum... |
22-Jul-2021 |
ShareCast |
GSK announces positive results for treatment of ... |
16-Jul-2021 |
ShareCast |
Wednesday broker round-up |
07-Jul-2021 |
ShareCast |
Elliott calls for leadership review at GSK |
01-Jul-2021 |
ShareCast |
Thursday broker round-up |
24-Jun-2021 |
ShareCast |
Deutsche upgrades GSK after strategy day |
24-Jun-2021 |
ShareCast |
GSK sets out ten-year vision, targets sales of £... |
23-Jun-2021 |
ShareCast |